Cargando…

Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells

Cancer cells have an increased need for glucose and, despite aerobic conditions, obtain their energy through aerobic oxidation and lactate fermentation, instead of aerobic oxidation alone. Glutamine is an essential amino acid in the human body. Glutaminolysis and glycolysis are crucial for cancer ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steifensand, Friederike, Gallwas, Julia, Bauerschmitz, Gerd, Gründker, Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467413/ https://www.ncbi.nlm.nih.gov/pubmed/34572047 http://dx.doi.org/10.3390/cells10092398

Ejemplares similares

Activation of G-Protein-Coupled Estrogen Receptor 1 (GPER1) Reduces Progression of Vulvar Carcinoma Cells
por: Loris, Johanna, et al.
Publicado: (2023)

Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion
por: Hellinger, Johanna W., et al.
Publicado: (2019)

Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer
por: Läsche, Matthias, et al.
Publicado: (2022)

Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer Cells
por: Kolb, Katharina, et al.
Publicado: (2020)

Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling
por: Hellinger, Johanna W., et al.
Publicado: (2020)

HPV and Other Microbiota; Who’s Good and Who’s Bad: Effects of the Microbial Environment on the Development of Cervical Cancer—A Non-Systematic Review
por: Läsche, Matthias, et al.
Publicado: (2021)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
por: Moon, Seo Yun, et al.
Publicado: (2021)

Tamoxifen Resistance in Breast Cancer
por: Chang, Minsun
Publicado: (2012)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol
por: Girgert, Rainer, et al.
Publicado: (2014)

Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer
por: Azzam, Hany N., et al.
Publicado: (2022)

The role of mitochondrial/metabolic axis in development of tamoxifen resistance in breast cancer
por: Azzam, Hany N., et al.
Publicado: (2023)

Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death
por: Läsche, Matthias, et al.
Publicado: (2020)

Inhibition of β-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line
por: Won, Hye Sung, et al.
Publicado: (2016)

Molecular prediction of tamoxifen resistance in breast cancer
por: Kok, M, et al.
Publicado: (2005)

Inhibition of tamoxifen's therapeutic effects by emodin in estrogen receptor-positive breast cancer cell lines
por: Kim, Yun Gyoung, et al.
Publicado: (2019)

Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression
por: Raha, Paromita, et al.
Publicado: (2015)

Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex
por: Lin, Yu-Ling, et al.
Publicado: (2016)

Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy
por: Girgert, Rainer, et al.
Publicado: (2012)

Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance
por: Bekele, Raie T., et al.
Publicado: (2016)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

An epigenomic approach to therapy for tamoxifen-resistant breast cancer
por: Feng, Qin, et al.
Publicado: (2014)

Molecular mechanisms and mode of tamoxifen resistance in breast cancer
por: Ali, Shazia, et al.
Publicado: (2016)

Association of tamoxifen resistance and lipid reprogramming in breast cancer
por: Hultsch, Susanne, et al.
Publicado: (2018)

Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer
por: Abdel-Hafiz, Hany A.
Publicado: (2017)

Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer
por: Yao, Jingwei, et al.
Publicado: (2020)

Sox2 promotes tamoxifen resistance in breast cancer cells
por: Piva, Marco, et al.
Publicado: (2014)

The role of Nanog expression in tamoxifen-resistant breast cancer cells
por: Arif, Khalid, et al.
Publicado: (2015)

Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF−7/SC Breast Cancer Cells
por: To, Ngoc Bao, et al.
Publicado: (2022)

Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer
por: Huang, Shuai, et al.
Publicado: (2019)

Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells
por: Li, Fujun, et al.
Publicado: (2019)

Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer
por: Tsoi, Ho, et al.
Publicado: (2022)

RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer
por: Xu, Zhi, et al.
Publicado: (2023)

Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer
por: Woo, Hye In, et al.
Publicado: (2017)

Alteration of Trop-2 expression in breast cancer cells by clinically used therapeutic agents and acquired tamoxifen resistance
por: Zhu, Jing, et al.
Publicado: (2022)

Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer
por: Fiorillo, Marco, et al.
Publicado: (2017)

TROP2 methylation and expression in tamoxifen-resistant breast cancer
por: Zimmers, Stephanie M., et al.
Publicado: (2018)

AFF3 upregulation mediates tamoxifen resistance in breast cancers
por: Shi, Yawei, et al.
Publicado: (2018)

Tamoxifen resistance-related ceRNA network for breast cancer
por: Qiao, Zipeng, et al.
Publicado: (2022)

The Role of Gonadotropin-Releasing Hormone in Cancer Cell Proliferation and Metastasis
por: Gründker, Carsten, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mk7av44hqi02v478ef53m16ugp